Sudarshan Pharma Industries LtdBSE: SUDARSHAN

Announcement under Regulation 30 (LODR)-Updates on Acquisition

· Issued by Sudarshan Pharma Industries Ltd via BSE India

Filed with BSE ·

In continuation of the Company''s disclosure dated 16/Jan/2025 regarding approval of the Board to acquire 300 shares of AED 1000/- each of M/s. Cibachem General Trading LLC, Dubai pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 this is to inform you that the Company ahs acquired 300 shares of M/s. Cibachem General Trading LLC, Dubai. Consequently, Cibachem has become a wholly-owned subsidiary of the Company.

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Sudarshan Pharma Industries Ltd on 6ix

Earlier from Sudarshan Pharma Industries

Later from Sudarshan Pharma Industries

All Sudarshan Pharma Industries news releases